Ipratropium and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Ipratropium
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed buprenorphine (a strong pain and opioid-type medicine) along with ipratropium (an inhaled medicine that helps you breathe). Both of these can slow down your gut and make it harder to pee. When they're used together, those effects can add up. In rare cases, the bowels can slow so much that they nearly stop, which is called a paralytic ileus.
The good news is this is a theoretical concern, and it's easy for your care team to keep an eye on. Watch for bad constipation, belly pain and bloating, or trouble urinating, and let your pharmacist or doctor know if any of those show up. Keep taking both as prescribed.
Effect: Additive risk of severe constipation, urinary retention, and potentially paralytic ileus.
Mechanism: Additive reduction in gastrointestinal motility. Buprenorphine (opioid) slows gut transit via mu-receptor effects, and ipratropium contributes anticholinergic effects on smooth muscle and bladder tone. Neither is a prodrug relevant here; this is a pharmacodynamic, not metabolic, interaction.
Evidence: Theoretical; severity rated major. Onset unspecified.
- Monitor for reduced bowel motility, abdominal distension, and urinary retention.
- Consider prophylactic bowel regimen and adequate hydration.
- Note that inhaled ipratropium has low systemic absorption, limiting real-world risk.
What happens
An increased risk of paralytic ileus
Interaction Deep Dive
When buprenorphine is given together with an anticholinergic agent, the combination may lead to urinary retention or to severe constipation that progresses to paralytic ileus. In patients receiving buprenorphine alongside anticholinergic drugs, watch for indications of urinary retention or diminished gastric motility1.
Why it happens (mechanism)
Additive effects on gastric motility
How to manage this interaction
Your care team can manage this well by keeping an eye on your gut and bladder function while you use both medicines.
- Keep taking both as prescribed unless your doctor or pharmacist tells you otherwise.
- Watch for warning signs: severe or worsening constipation, belly pain or swelling, no bowel movements, or trouble passing urine.
- Report any of these to your pharmacist or prescriber promptly.
- Ask your pharmacist whether a stool softener or laxative and good hydration make sense for you.
Your team may monitor you more closely and adjust your plan if needed.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Ipratropium and Buprenorphine together?
Using buprenorphine with ipratropium can add up to slow your gut and bladder, so watch for severe constipation, belly swelling, or trouble urinating and report them, while continuing both as prescribed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Ipratropium and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Ipratropium and Buprenorphine interaction managed?
Your care team can manage this well by keeping an eye on your gut and bladder function while you use both medicines. Keep taking both as prescribed unless your doctor or pharmacist tells you otherwise. Watch for warning signs: severe or worsening constipation, belly pain or swelling, no bowel movements, or trouble passing urine. Report any of these to your pharmacist or prescriber promptly. Ask yo… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Ipratropium or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Keep reading about Buprenorphine
Keep reading about Ipratropium
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist